ACIP review of the hepatitis B birth dose vaccination remains a grave concern - Please read more here.

Site Search

You searched for "hepatitis D"

  • Raising Awareness about Hepatitis B in African Immigrant Communities in the US

    Hepatitis B Foundation Health Outreach Coordinator and Guest Blogger Sierra Pellechio, B.S., CHES discusses her work with the African Immigrant community.    Hepatitis B affects over 2 million people in the United States, disproportionately affecting Asian, Pacific Islander and African Immigrant (AI) communities in the U.S. Although partners around the U.S. have been trying to increase awareness and improve screening and linkage to care rates among high risk communities, there have been few programs designed to address the urgent need for intervention among U.S. AI communities. An estimated 5% to 18% of African immigrants in the U.S. are affected by hepatitis B, with less than 20% aware of their infection. However, since research and prevalence data specific to AIs are lacking, it has been difficult to understand the true burden of this disease. One thing we do know is that there are significant knowledge gaps and low screening and linkage to care rates in AI communities. If left undiagnosed, people with hepatitis B are at risk of developing liver complications, including cirrhosis and liver cancer, which can lead to premature death, making it vital to identify those affected. This is complicated by the fact that hepatitis B is a silent disease with few or no symptoms for decades. Last year, the Hepatitis B Foundation, in collaboration with the Centers for Disease Control and Prevention (CDC) and CHIPO (Coalition Against Hepatitis for People of African Origin) launched a pioneering project to create a broad scale educational initiative to promote hepatitis B awareness and testing for AIs across the United States.  The project aims to increase awareness, testing, linkage to care and vaccination among AI’s to align with the goals of the March 2017 “A National Strategy for the Elimination of Hepatitis B and C” by the U.S. National Academies of Sciences, Engineering, and Medicine (NASEM). This strategy set the goal of eliminating hepatitis B as a public health

    http://www.hepb.org/blog/raising-awareness-hepatitis-b-african-immigrant-communities-us/
  • Hepp-B Valentine’s Day: What to do on Valentine’s Day when you have hepatitis B.

    Happy Valentine’s Day!! Today is dedicated to celebrating love. Though it can be exciting, anxiety can creep up on this day too. Maybe you’re thinking about confessing your feelings to your crush? Or nervous about planning the best date ever? Maybe you’re timid about the holiday in general because of your hepatitis B status? If you have chronic hep B, you may think that starting a relationship and initiating sex can be stressful and feel overwhelming. Questions like “What if we break up because I disclosed my status?” or “Can I even start a relationship with someone if I have a chronic disease like hepatitis B?” may be swimming in your mind. Doubt and anxiety may overwhelm your thoughts, but don’t forget that you’re more than your illness. You should not focus on things you cannot change. You are worthy of love and can live out that romantic story you always wanted because you have wonderful things to offer to a future love interest. If you’re spending time with someone on Valentine’s this year or any day, it’s important that you remember to take precautions if your date leads to an intimate night. If you are living with hep B, properly wearing a latex condom keeps you safe from becoming co-infected with another infectious disease. No one wants a co-infection. It is complicated and potentially dangerous for you and your partner’s health. If your partner does not have hep B, then avoid infection by wearing a condom. Hep B is vaccine preventable, but hepatitis C, HIV and other sexually transmitted infections (STIs) are not. Considering the health and safety of yourself and your sexual partners is paramount. You may not know what they have, and they may not know what you have. Also, it is important to disclose your status before sex (even if it’s safe sex with a condom). You may jeopardize your partner’s trust (and their health) before the relationship deepens. Disclosing your chronic hep B status can be scary, but talking about it

    http://www.hepb.org/blog/hepp-b-valentines-day-valentines-day-hepatitis-b/
  • Adoption and Hepatitis B

    Have you been thinking about adoption for a long time or have been inspired by NBC’s show, This is Us, to adopt? Adoption is exciting! However, it can be nerve wracking and feel overwhelming. We at the Hepatitis B Foundation can help with one aspect of the adoption process – making sure you have accurate information about hepatitis B. It is important to be armed with accurate information about hepatitis B when preparing for adoption for both international and domestic adoptions. This can help protect your future child, family members and yourself when you welcome your future child with open arms. Many people wish to adopt children from countries where hepatitis B infections are common: Asia, South America, Eastern Europe, and some parts of Africa. Children from these regions could be infected with the virus since it can be unknowingly passed from birth mothers who have hepatitis B and transmit the disease to their children during delivery. In addition, many of these countries struggle with proper infection control practices that place babies and young children at risk with unsafe medical procedures. Unfortunately, many infants still do not have access to the birth dose of the hepatitis B vaccine to help prevent transmission. Domestic adoptions also present some risk. Children born to women in high-risk groups (e.g. illicit drug users, multiple sexual partners, etc.) could be exposed to hepatitis B at birth. In addition, children from group homes are at increased risk for hepatitis B infection. The good news is that there are procedures in place that can prevent a baby from getting infected if born to an infected mother – and the success rate is up to 95%! This includes providing the first dose of the hepatitis B vaccine along with a dose of hepatitis B immune globulin (HBIG) within 12 hours of birth. If you are planning a U.S. adoption, and know that the birth mother is infected, you can ensure that the birth hospital knows about these procedures and can

    http://www.hepb.org/blog/adoption-hepatitis-b/
  • Journey to the Cure: What is Hepatitis B? ft. Timothy Block, PhD

    Welcome to Journey to the Cure. This is a web series that chronicles the progress at the Hepatitis B Foundation and Baruch S. Blumberg Institute towards finding the cure for hepatitis B. In the first episode (part 1), Kristine Alarcon, MPH sits down with Timothy Block, PhD, President and Co-Founder of the Hepatitis B Foundation, to talk about the basics of hepatitis B. For any questions about hepatitis B, please email info@hepb.org The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the lives of those affected by hepatitis B worldwide through research, education and patient advocacy. Visit us at www.hepb.org, on Facebook at www.facebook.com/hepbfoundation, on Twitter at twitter@hepbfoundation, and our Blog at www.hepb.org/blog Disclaimer: The information provided in this video is not intended to serve as medical advice or endorsement of any product. The Hepatitis B Foundation strongly recommends each person discuss this information and their questions with a qualified health care provider. Edited by: Samantha Young Music: Modern - iMovie Library Collection

    http://www.hepb.org/blog/journey-cure-hepatitis-b-ft-timothy-block-phd/
  • Checking In on Your New Years’ Resolutions for Hepatitis B

    How are your New Years’ Resolutions going?  When you were making your resolutions, did you consider hepatitis B specific New Year’s resolutions?  Here are a few ideas… Make an appointment to see your liver specialist.  If you have hepatitis B, and you are not being seen regularly by a liver specialist, or a doctor knowledgeable about hepatitis B every six months, then make the commitment to do so this year. It is important to know and keep track of your HBV status and your liver health. Check out HBF’s Directory of Liver Specialists. We do not have names and contact information for all countries, so please feel free to share your favorite liver specialist with the HBV community. Make an appointment today!   Organize your hepatitis B lab dataand make a table with the date of the blood draw and the associated blood test results. You’ll want to start by requesting copies of all of your labs from your doctor. Then you can generate data tables using Excel, Word or a pencil and paper table for your charted data.  It will help you visualize your HBV over time, and you may find your doctor likes to see both the lab results and your table of results.   Generate a list of questionsfor your next appointment with your liver specialist.  People get nervous anticipating what their doctor might say about their health. It is very easy to forget those important questions, so be sure to write them down, or add them to a note app on your phone or tablet. If the option is available, have a family member or friend attend the appointment with you. That will allow you to pay closer attention while your friend or family member takes notes for you.   Have you received a vaccine for hepatitis A? The HAV vaccine is recommended for children and adults living with HBV. The vaccine will protect you from another liver virus and additional stress to your liver.  There is no vaccine available for HCV, HDV, or for HIV, so please take precautions to

    http://www.hepb.org/blog/checking-new-years-resolutions-hepatitis-b/
  • Marshallese

    Ruwainene tok nan Kajin Majol Jebta eo ikijen Ejaak in Webjait eo kin Hepatitis B Hepatitis B ej kwalok ke ej juon kij ejab jedmatmat, im elon armej rejab jela ke reboke. Webjait in eped melele ko kin waween boprae, kakolkol lale im keplaak hepatitis B. Kemij rejan iok nan kajeded melele kein ipen ro jeram, baamle im ro jet ilo jukjuk in bed eo am. Jet kein waween raorok nan kememej ikijen hepatitis B: Hepatitis B ejab itok jen bodan – ej walok jen juon kij.  Ewor juon wa eo etiljok eo enaj kejbarok iok jen hepatitis B nan indeo.  Ewor juon kakolkol nan bok botoktok eo emlak nan kakilen naninmej in hepatitis B.  Ewor jekjek ko nan komadmod. Hepatitis B ej juon Naninmej eo Ebedjake Aolepen Lal Hepatitis B emaron jelet jabrewot armej jabrewot iio ak rilal, ijoke armej ro jen kajojo jikin ko hepatitis B eka an walok, einwot Ejia, motan ko ilo Abrika im Turok in Amedka, Turear in Iorob, im Iolab Rear, rej ijoko elab an kawotata ilo aer bok naninmej in. Hepatitis B ej bar lab an walok ipen ri Amedka ro rekar lotak (ak ro jineer jemeer rekar lotak) ilo jikin kein. Ewor jubwiki in milion jonan armej ilo lalin ro ewor aer hepatitis B. Elon armej rejab lukin jela ke reboke, im ejelok kein kakolkol ko – ijoke ewor waween ko raorok koj aikwij in jela. Bok kakolkol ko kin hepatitis B emaron kejbarok mour eo am. Elane kojela bwe ewor am hepatitis B, komaron koman kelet ko nan ejmour eo am bwe deka in jibuke eo am en ejmourur im komaron lolok juon takto eo enaj jipan iok jela kilen kejbarok im boprae jen an joreen aj eo. Hepatitis B Foundation ej juon doulul ilo kien jaab nan worlok nan wot bukot juon jekjek eo najnkemour im lonaj lonlok mour an ro hepatitis B ejelet er ipelaak in lal iloan ekatak ko, jelelokijen im naan in kokjoor nan rinaninmej. Riketak: Melele ko reped ilo wepjait in rej nan un ko katakin wot. Hepatitis B Foundation eo ejab juon doulul nan takto. Jouj im kenono ipen takto eo am ak juon eo etijemlok ilo lelok ejmour nan jipan kejbarok im kokabiloklok. Welcome to the Marshallese Chapter of the Hepatitis B Foundation Website Hepatitis B is known as a silent disease, and most people don’t even know they are infected. This website contains information about preventing, diagnosing and managing hepatitis B. We encourage you to share this information with your friends, family and others in your community. Here are some important things to remember about hepatitis B: Hepatitis B is not inherited - it is caused by a virus.  There is a safe vaccine which will protect you from hepatitis B for life.  There is a simple blood test to diagnose hepatitis B.  There are treatment options. Hepatitis B is a Global Disease Hepatitis B can infect any person of any age or ethnicity, but people from parts of the world where hepatitis B is common, such as Asia, parts of Africa and South America, Eastern Europe, and the Middle East, are at much higher risk for getting infected. Hepatitis B is also common among Americans who were born (or whose parents were born) in these regions. There are hundreds of millions of people worldwide who have hepatitis B. Most people don’t even know they are infected, and don’t have symptoms – but there are many important things you should know. Getting tested for hepatitis B can save your life. If you know you have hepatitis B, you can make lifestyle choices to keep your liver healthy and you can see a doctor to help manage the virus and prevent liver damage. The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and helping to improve the quality of life for all those affected by hepatitis B worldwide through research, education and patient advocacy. Disclaimer: The information that is provided on this website is for educational purposes only. The Hepatitis B Foundation is not a medical organization. Please talk to your doctor or a qualified health care provider for personal medical care and advice. 

    https://www.hepb.org/languages/marshallese/
  • Resources for Educators

    These resources are part of the Centers for Disease Control and Prevention's Know Hepatitis B campaign to raise awareness about and promote testing for hepatitis B in high-risk communities in the U.S. These materials are the result of a collaboration between CDC, Hepatitis B Foundation, and CHIPO partners, and were pilot tested in the community to ensure cultural and content relevancy. We encourage you to download, print and share these resources widely! If you would like to request that any already printed materials be shipped to you, free of charge, please complete this form. For questions and support, email info@hepb.org.  Training and Community Resources Hepatitis B Presentation for Community Health Workers Hepatitis B Flipchart for Community Health Education (CDC's Product of the Month April 2020!) Hepatitis B Resources for Communities in East Africa Fact Sheets and Printable Resources Locating Hepatitis B Testing Resources Using the Hepatitis B Flipchart for Community Education Printable Hepatitis B Takeaway Card (English) Printable Hepatitis B Takeaway Card (French) Printable Hepatitis B Takeaway Card (Swahili) Printable Hepatitis B Takeaway Card (Amharic) Printable Hepatitis B Takeaway Card (Arabic) #JustB Hepatitis B African Storyteller Videos Bright's Hepatitis B Story (Ghanaian Storyteller) [embed width="309" height="175" class="leftAlone" thumbnail="https://i.ytimg.com/vi/9xhSvLR0x-s/hqdefault.jpg?r"]http://www.youtube.com/watch?v=9xhSvLR0x-s&feature=emb_imp_woyt[/embed] Youtube - English       Youtube - Twi William's Hepatitis B Story (Ghanaian Storyteller) [embed width="321" height="181" class="leftAlone" thumbnail="https://i.ytimg.com/vi/iphhwnShMpU/hqdefault.jpg?r"]http://www.youtube.com/watch?v=iphhwnShMpU&feature=emb_imp_woyt[/embed] Youtube - English Adama's Hepatitis B Story (Senegalese Storyteller) [embed width="325" height="244" class="leftAlone" thumbnail="https://i.ytimg.com/vi/AQMqsmijvgo/hqdefault.jpg?r"]http://www.youtube.com/watch?v=AQMqsmijvgo&t=3s[/embed] YouTube - English     YouTube - French     YouTube - Mandingo Ismail's Hepatitis B Story (Nigerian Storyteller) [embed width="326" height="184" class="leftAlone" thumbnail="https://i.ytimg.com/vi/z6LB3cmEsyk/hqdefault.jpg?r"]http://www.youtube.com/watch?v=z6LB3cmEsyk[/embed] YouTube - English Gold's Hepatitis B Story (Nigerian Storyteller) [embed width="319" height="180" class="leftAlone" thumbnail="https://i.ytimg.com/vi/UiT8yUyqGjw/hqdefault.jpg?r"]http://www.youtube.com/watch?v=UiT8yUyqGjw[/embed] YouTube - English Bunmi's Hepatitis B Story (Nigerian Storyteller) [embed width="323" height="182" class="leftAlone" thumbnail="https://i.ytimg.com/vi/GQ1zzQwwmmM/hqdefault.jpg?r"]http://www.youtube.com/watch?v=GQ1zzQwwmmM[/embed] Youtube - English FK's Hepatitis B Story (Storyteller from Burkina Faso) [embed width="323" height="182" class="leftAlone" thumbnail="https://i.ytimg.com/vi/Hz6xFNtIKdE/hqdefault.jpg?r"]http://www.youtube.com/watch?v=Hz6xFNtIKdE&feature=emb_imp_woyt[/embed] YouTube - English      YouTube - French Sonia's Hepatitis B Story (Nigerian Storyteller) [embed width="323" height="182" class="leftAlone" thumbnail="https://i.ytimg.com/vi/Kd22voWXwGk/hqdefault.jpg?r"]http://www.youtube.com/watch?v=Kd22voWXwGk[/embed] YouTube - English John's Hepatitis B Story (Nigerian Storyteller) [embed width="320" height="181" class="leftAlone" thumbnail="https://i.ytimg.com/vi/7Zj6SQYXmUk/hqdefault.jpg?r"]http://www.youtube.com/watch?v=7Zj6SQYXmUk[/embed] YouTube - English Dayo's Hepatitis B Story (Nigerian Storyteller) [embed width="323" height="182" class="leftAlone" thumbnail="https://i.ytimg.com/vi/Jb0eqyeVDcQ/hqdefault.jpg?r"]http://www.youtube.com/watch?v=Jb0eqyeVDcQ[/embed] YouTube - English

    https://www.hepb.org/research-and-programs/chipo/resources/resources-for-educators/
  • Funding Opportunities

    Several new opportunities for funding of hepatitis B and liver cancer/ hepatocellular carcinoma (HCC) research are currently available.  Below you will find summaries of recently announced opportunities from the United States (US) National Institutes of Health (NIH).   Note that the NIH can only support grants for HBV and HCC research if people submit them.  To address this obstacle, we are encouraging them to establish dedicated funding for HBV and HCC to stimulate more applications.  We encourage researchers to pass this information to colleagues, submit your own applications, and help with advocacy for HBV and HCC whenever possible.  It is also important to note that most NIH grants can involve or be from non-US sources.  Check eligibility requirements.   Please be sure to review the key dates, especially the expiration date as some of these announcements are set to renew.   *UPCOMING SBIR Contract in FY2020- Antiviral Drugs To Cure Chronic Hepatitis B Virus Infection. NIAID topic for NIH SBIR contract solicitation. https://www.niaid.nih.gov/grants-contracts/january-2019-dmid-council-approved-concepts?utm_campaign=+36681533&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=   *NIH/NIAID- Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-Infection (RO1 Clinical Trial Not Allowed: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative basic, translational, and clinical research to identify and address the challenges to achieving hepatitis B virus (HBV) cure in the presence or absence of human immunodeficiency virus (HIV). https://grants.nih.gov/grants/guide/pa-files/PAS-19-097.html   *NIH/NIAID- HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21): The purpose of this Funding Opportunity Announcement (FOA) is to fill scientific gaps needed to (a) inform HBV functional cure strategies by furthering our understanding of unique challenges impacting HBV and HIV co-infected hosts and (b) advance the discovery and development of novel HBV interventions that are safe and achieve a functional cure in HIV and HBV co-infected individuals. https://grants.nih.gov/grants/guide/pa-files/pa-17-278.html   *NIH/NCI- Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 and R01 - Clinical Trial Not Allowed):The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. https://grants.nih.gov/grants/guide/pa-files/pa-18-677.html   NIH/NIDA/NIAAA- Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional): This Funding Opportunity Announcement (FOA) for R34 applications seeks to support: (a) pilot and/or feasibility testing of innovative new, revised, or adapted prevention intervention approaches to prevent or delay the initiation and onset of drug and alcohol use, the progression to misuse or problem use or alcohol and other substance use disorder, reduce drinking and driving and deaths related to impaired driving, and the drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis  among diverse populations and settings; and, (b) pre-trial feasibility and acceptability testing for prevention services and systems research. It is expected that research conducted via this R34 mechanism will consist of studies that are a pre-requisite for preparing and submitting subsequent applications for larger scale drug or alcohol abuse prevention and/or drug- or alcohol-related HIV prevention intervention studies. This R34 FOA does not support applications for which the sole focus is development of intervention protocols, manuals, or the standardization of protocols. Any intervention development work must be embedded within a pilot/feasibility study. Of particular interest is prevention research that addresses current public health priorities and priority settings and systems. https://grants.nih.gov/grants/guide/pa-files/pa-18-775.html   NIH/-NICHD- Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01 Clinical Trial Optional): The purpose of this funding opportunity announcement (FOA) is to stimulate investigations including translational, epidemiologic and clinical studies and trials that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. NICHD is committed to supporting research that will increase scientific understanding of and treatments for high-priority perinatal infections. https://grants.nih.gov/grants/guide/pa-files/PA-18-031.html   *NIH/NIMHD/NIAAA/NCI- Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21)- The purpose of the initiative is to support multidisciplinary innovative exploratory and developmental research to understand the underlying etiologic factors and the mechanisms that result in disparities in chronic liver diseases and cancer in the US. This FOA utilizes the Research Project Grant (R21) mechanism, and is suitable for early phase, pilot, or exploratory/developmental projects.  Investigators who are interested in proposing larger scale, later phase projects based upon substantial preliminary data should submit applications to the companion FOA PAR-17-151 of identical scientific scope which uses the NIH (R01) grant mechanism.  https://grants.nih.gov/grants/guide/pa-files/PAR-17-150.html  

    https://www.hepb.org/research-and-programs/research-for-a-cure/research-funding-opportunities/

  • Maligayang Pagdating sa Tagalog na Kabanata ng Hepatitis B Foundation Website Ang hepatitis B ay kilala bilang isang tahimik na sakit, at karamihan sa mga tao ay hindi alam na sila ay nahawahan. Ang website na ito ay naglalaman ng impormasyon tungkol sa pagpigil, pagsuri at pangangasiwa ng hepatitis B. Hinihimok ka namin na ibahagi ang impormasyong ito sa iyong mga kaibigan, pamilya at iba pa sa inyong komunidad. Narito ang ilang mahahalagang bagay na dapat tandaan tungkol sa hepatitis B: Ang hepatitis B ay hindi namamana – ito ay sanhi ng virus. 
 Mayroong ligtas na bakuna na magpoprotekta sa iyo mula sa hepatitis B nang panghabang buhay. 
 Mayroong simpleng pagsusuri sa dugo upang matukoy ang hepatitis B. 
 Mayroong mga opsyon sa paggagamot. Ang hepatitis B ay Isang Pandaigdigang SakitMaaaring mahawa ng hepatitis B ang sinumang tao sa anumang edad o etnisidad, ngunit ang mga tao mula sa mga bahagi ng mundo kung saan karaniwan ang hepatitis B, tulad ng Asya, mga bahagi ng Aprika at Timog Amerika, Silangang Europa, at Gitnang Silangan, ay may mas mataas na panganib na mahawahan. Karaniwan din ang hepatitis B sa mga Amerikanong ipinanganak (o ang mga magulang ay ipinanganak) sa mga rehiyong ito. Daan-daang milyong tao sa buong mundo ang may hepatitis B. Karamihan sa mga tao ay hindi alam na sila ay nahawahan, at walang mga sintomas – ngunit maraming mahahalagang bagay ang dapat mong malaman. Ang pagpapasuri para sa hepatitis B ay makakapagligtas ng iyong buhay. Kung alam mong mayroon kang hepatitis B, maaari kang gumawa ng mga pasya sa pamumuhay upang mapanatiling malusog ang iyong atay at maaari ka ring magpatingin sa doktor upang matulungang pangasiwaan ang virus at maiwasan ang pinsala sa atay. Ang Hepatitis B Foundation ay isang pambansang hindi-pangkalakal na organisasyon na nakatuon sa paghahanap ng lunas at tumutulong na mapabuti ang kalidad ng buhay para sa lahat na apektado ng hepatitis B sa buong mundo sa pamamagitan ng pananaliksik, edukasyon at pagtataguyod ng pasyente. Pagtatatwa: Ang impormasyong ibinigay sa website na ito ay para sa mga layuning pang-edukasyon lamang. Ang Hepatitis B Foundation ay hindi isang medikal na organisasyon. Mangyaring kausapin ang iyong doktor o ang isang k’walipikadong tagapagbigay ng pangangalagang pangkalusugan para sa personal na medikal na pangangalaga at payo. Welcome to the Tagalog Chapter of the Hepatitis B Foundation Website Hepatitis B is known as a silent disease, and most people don’t even know they are infected. This website contains information about preventing, diagnosing and managing hepatitis B. We encourage you to share this information with your friends, family and others in your community. Here are some important things to remember about hepatitis B: Hepatitis B is not inherited - it is caused by a virus. 
 There is a safe vaccine which will protect you from hepatitis B for life. 
 There is a simple blood test to diagnose hepatitis B. 
 There are treatment options. Hepatitis B is a Global DiseaseHepatitis B can infect any person of any age or ethnicity, but people from parts of the world where hepatitis B is common, such as Asia, parts of Africa and South America, Eastern Europe, and the Middle East, are at much higher risk for getting infected. Hepatitis B is also common among Americans who were born (or whose parents were born) in these regions. There are hundreds of millions of people worldwide who have hepatitis B. Most people don’t even know they are infected, and don’t have symptoms – but there are many important things you should know. Getting tested for hepatitis B can save your life. If you know you have hepatitis B, you can make lifestyle choices to keep your liver healthy and you can see a doctor to help manage the virus and prevent liver damage. The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and helping to improve the quality of life for all those affected by hepatitis B worldwide through research, education and patient advocacy. Disclaimer: The information that is provided on this website is for educational purposes only. The Hepatitis B Foundation is not a medical organization. Please talk to your doctor or a qualified health care provider for personal medical care and advice.

    https://www.hepb.org/languages/tagalog/
  • Hepatitis B Foundation Mourns the Loss of Pioneering Hepatitis B Physician-Scientist Dr. W. Thomas London

    Dr. London was Long-time Board Member, Medical Advisor, and Mentor DOYLESTOWN, PA (June 3, 2017): W. Thomas London, MD, an internationally renowned physician-scientist dedicated to the study of hepatitis B, passed away June 3 at the age of 85. Dr. London was a key member of the research team that discovered the hepatitis B virus in the early 1960s, and longtime member of the Board of the Hepatitis B Foundation and its research arm, the Baruch S. Blumberg Institute, where he also served as a distinguished scientific and medical advisor. Dr. London represented the very best in a doctor and scientist - sincere compassion, and successful achievement in advancing the cause and cure of hepatitis B. His wisdom and guidance will be greatly missed.  “This is a terrible loss. Tom London was not only one of the finest medical and scientific minds, but a gracious, caring doctor, who always had time for patients and fellows, no matter how busy he was," said Timothy Block, PhD, President, Hepatitis B Foundation and its Blumberg Institute. “He was a role model, and an inspiration for me, and for a generation. One of a kind.”  In the 1966, Dr. London left his position at the National Institute of Health (NIH) to work with Dr. Baruch S. Blumberg at the Fox Chase Cancer Center in Philadelphia. Dr. London and colleagues made the first correlation between a then newly identified virus and hepatitis, a serious infection of the liver. Dr. Blumberg went on to receive the Nobel Prize for the discovery of the new hepatitis B virus, but always acknowledged the critical role of Dr. London in linking the new virus to a clinical disease known as “hepatitis” or serious liver inflammation. Dr. London remained at Fox Chase where his research contributed to linking the hepatitis B  virus to primary liver cancer, and continued to work on epidemiologic studies and large community-based screening and vaccination programs in the Philadelphia area, Haimen City, China, and Senegal, West Africa. Those programs have become models of public health outreach in the effort to prevent and control an infectious disease like hepatitis B. In 2009, Dr. London retired from Fox Chase as a Senior Member, after which he volunteered his professional time working with the public health professionals at the Hepatitis B Foundation and research scientists at the Blumberg Institute, both headquartered in Doylestown, PA. He devoted his entire career to research on the etiology, pathogenesis, and prevention of primary liver cancer (or hepatocellular carcinoma, HCC) with particular emphasis on the epidemiology of chronic hepatitis B infection. In 2015, to recognize the extraordinary contributions of Dr. London, the Blumberg Institute created the W. Thomas London Distinguished Professorship.  At the ceremony to celebrate the named professorship, Harvey Alter, MD, eminent scientist at the NIH and co-discoverer of the hepatitis B virus (and C virus), described the seminal contributions of Dr. London as "world changing in magnitude, but done quietly, and modestly." “Dr. London inspired my career in infectious disease,” says Nathaniel Brown, MD, infectious disease physician, retired pharmaceutical executive focused on hepatitis B drug development, and Board Member of the Hepatitis B Foundation. "This is a great loss for the hepatitis B community." Dr. London is a graduate of Oberlin College and Cornell University Medical College. He received his clinical training in Internal Medicine at Bellevue Hospital and the Memorial Sloan-Kettering Cancer Center in New York City. His work has resulted in more than 285 publications, election as a Fellow of the American Association for the Advancement of Science, editor of prestigious peer-reviewed cancer journals, and many awards. He was a resident of Wyncote, PA, and is survived by his wife Linda, with whom he just celebrated 60 years of marriage, and their 4 daughters and 8 grandchildren. Relatives and friends are invited to memorial services on Thursday, June 8 at 2:00 pm at Goldsteins’ Rosenberg’s Raphael Sacks, 6410 N. Broad Street, Philadelphia, PA 19126. Immediately following services, the family will host a reception. Contributions in his memory may be made to the Hepatitis B Foundation, 3805 Old Easton Road, Doylestown, PA 18902, www.hepb.org, or to the Cheltenham Township Adult School, 500 Rices Mill Road, Wyncote, PA 19095, www.cheltenhamtownshipadultschool.org       About the Hepatitis B Foundation: The Hepatitis B Foundation is the nation’s leading nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to www.hepb.org, read our blog at http://hepb.org/blog, follow us on Twitter @HepBFoundation, find us on Facebook at www.facebook.com/hepbfoundation or call 215-489-4900. About the Baruch S. Blumberg Institute: The Baruch S. Blumberg Institute is an independent, nonprofit research institute established in 2003 by the Hepatitis B Foundation to fulfill its research mission and to conduct discovery research and nurture translational biotechnology in an environment conducive to interaction, collaboration and focus. It was renamed in 2013 to honor Baruch S. Blumberg, who won the Nobel Prize for his discovery of the hepatitis B virus and co-founded the Hepatitis B Foundation. To learn more, visit www.blumberginstitute.org. # # #

    https://www.hepb.org/news-and-events/news-2/london/